Machine-Learning Exploration of Exposure-Effect Relationships of Cisplatin in Head and Neck Cancer Patients
Background: Cisplatin is a pivotal drug in the treatment of head and neck cancer, and personalized dosage should help the preservation of an optimal toxicity-efficacy ratio. Methods: We analyzed the exposure-effect relationships of 80 adult patients with head and neck cancers and treated with standa...
Saved in:
Main Authors: | Céleste Cauvin (Author), Laurent Bourguignon (Author), Laure Carriat (Author), Abel Mence (Author), Pauline Ghipponi (Author), Sébastien Salas (Author), Joseph Ciccolini (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer
by: Jiying Yang, et al.
Published: (2017) -
Mechanistic models for hematological toxicities: Small is beautiful
by: Laure Deyme, et al.
Published: (2021) -
miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Nadine De Godoy Torso, et al.
Published: (2023) -
Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma
by: Fayette J, et al.
Published: (2015) -
Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer
by: Benjamin K. Schneider, et al.
Published: (2019)